The global infection control market size was valued at USD 55.3 billion in 2025 and is projected to grow from USD 59.06 billion in 2026 to USD 99.97 billion by 2034, registering a CAGR of 6.8% during the forecast period from 2026 to 2034. North America dominated the infection control market with a market share of 38.4% in 2025.
Infection control refers to the set of evidence-based practices, procedures, and preventive measures implemented to reduce the transmission of infectious microorganisms in healthcare and community settings. It includes hand hygiene, sterilization, disinfection, personal protective equipment (PPE), isolation protocols, environmental cleaning, and surveillance programs. Infection control plays a vital role in protecting patients, healthcare professionals, and the public by preventing healthcare-associated infections and improving overall safety.
Download a Free Sample To learn more about this report,
Growing Adoption of AI-Enabled Infection Prevention and Smart Disinfection Technologies
The infection control market trends are being driven by the increasing focus on healthcare-associated infection prevention, stricter hygiene regulations, and the growing adoption of advanced disinfection technologies. Hospitals, clinics, diagnostic laboratories, and long-term care facilities are increasingly investing in automated sterilization systems, ultraviolet (UV-C) disinfection, hydrogen peroxide vapor systems, and antimicrobial products to reduce the risk of cross-contamination. Artificial intelligence (AI) and Internet of Things (IoT)-enabled monitoring systems are also being integrated into infection control programs to track hygiene compliance, monitor environmental conditions, and improve cleaning efficiency. In addition, the growing number of surgical procedures, rising antimicrobial resistance, and expanding healthcare infrastructure are encouraging healthcare providers to strengthen infection prevention strategies through advanced equipment, digital monitoring, and standardized sterilization protocols.
These developments indicate that artificial intelligence, automated disinfection technologies, IoT-enabled monitoring, and advanced sterilization systems will remain the key infection control market trends, improving patient safety, strengthening infection prevention, and driving long-term growth across global healthcare facilities.
Increasing Prevalence of Healthcare-Associated Infections and Stringent Safety Regulations
The infection control market is expanding due to the rising prevalence of healthcare-associated infections (HAIs) and the growing implementation of stringent infection prevention protocols across healthcare facilities. Hospitals, diagnostic laboratories, and ambulatory care centers are increasingly adopting sterilization equipment, disinfectants, personal protective equipment, and infection surveillance systems to improve patient and healthcare worker safety. Rising healthcare expenditure, expanding healthcare infrastructure, and increasing awareness of hygiene standards are further accelerating market demand. These developments are significantly contributing to infection control market growth as healthcare providers strengthen infection prevention strategies.
High Implementation Costs and Compliance Challenges
The infection control market faces challenges due to the high cost of advanced sterilization systems, infection surveillance technologies, and continuous compliance with evolving healthcare regulations. Healthcare providers must invest significantly in equipment upgrades, staff training, and quality assurance programs to maintain infection control standards. In addition, resource limitations in developing healthcare systems and increasing operational costs continue to affect the adoption of advanced infection prevention technologies. Recent infection control market analysis indicates that these factors remain significant barriers to market expansion.
Expansion of Automated Disinfection Technologies and AI-Based Infection Surveillance
The infection control market is expected to benefit from increasing adoption of automated disinfection systems, artificial intelligence, and digital infection surveillance platforms. Healthcare providers are investing in ultraviolet disinfection systems, hydrogen peroxide vapor technologies, and AI-powered monitoring tools to reduce healthcare-associated infections and improve operational efficiency. Growing investments in smart hospitals and healthcare digitalization are also creating significant growth opportunities. These developments are expected to strengthen the infection control market size by accelerating the adoption of advanced infection prevention technologies worldwide.
Managing Antimicrobial Resistance and Maintaining Consistent Infection Prevention Standards
The infection control market continues to face challenges related to antimicrobial resistance, evolving pathogen profiles, and maintaining consistent infection prevention practices across healthcare facilities. Healthcare organizations must continuously update infection control protocols, improve surveillance capabilities, and ensure regulatory compliance while managing increasing patient volumes. Workforce shortages and the need for ongoing staff education also require sustained investment. According to recent infection control market reports, companies are investing in advanced sterilization technologies, digital surveillance platforms, and healthcare training programs to improve infection prevention outcomes and strengthen long-term healthcare safety.
Sterilization Equipment Segment is Projected to Register the Fastest Growth at a CAGR of 7.8%
The sterilization equipment segment is projected to register the fastest growth at a CAGR of 7.8% during 2026–2034. In 2025, the segment accounted for 58.7% of the global infection control market, with a value of USD 32.46 billion. Growth is driven by increasing emphasis on preventing healthcare-associated infections, rising surgical volumes, and growing investments in advanced sterilization technologies across healthcare facilities. Stringent regulatory standards for infection prevention continue to support the segment's growth.
The protective barriers segment continues to maintain a significant market presence owing to the increasing use of personal protective equipment, disposable medical supplies, and barrier products to minimize the risk of cross-contamination. Growing awareness of infection prevention and workplace safety continues to strengthen demand for protective barriers across healthcare settings.
Request Customizationto receive a tailored report.
Pharma and Biotech Companies Segment is Projected to Register the Fastest Growth at a CAGR of 8.2%
The pharma and biotech companies segment is projected to register the fastest growth at a CAGR of 8.2% during 2026–2034. In 2025, the segment accounted for 34.8% of the global infection control market, with a value of USD 19.24 billion. Growth is driven by increasing pharmaceutical manufacturing activities, expanding biologics production, and stringent sterilization requirements to maintain product quality and regulatory compliance. Rising investments in advanced manufacturing facilities continue to support the segment's growth.
The medical device sterilization segment dominated the market owing to the growing production of reusable and disposable medical devices, stringent infection prevention protocols, and increasing regulatory requirements for device safety. The others segment continues to witness steady demand through expanding infection control applications across research laboratories, diagnostic facilities, and other healthcare environments.
Ambulatory Surgical Centers Segment is Projected to Register the Fastest Growth at a CAGR of 8.1%
The ambulatory surgical centers segment is projected to register the fastest growth at a CAGR of 8.1% during 2026–2034. In 2025, the segment accounted for 24.6% of the global infection control market, with a value of USD 13.60 billion. Growth is driven by the increasing number of outpatient surgical procedures, rising focus on infection prevention, and expanding investments in advanced sterilization and disinfection systems. Growing preference for minimally invasive procedures continues to support the segment's growth.
The hospitals segment dominated the market owing to the high volume of patient admissions, surgical procedures, and critical care services requiring comprehensive infection prevention measures. The others segment continues to support market growth through increasing adoption of infection control products across clinics, diagnostic centers, long-term care facilities, and other healthcare settings.
Speak to an Analystto discuss market opportunities.
North America infection control market accounted for 38.4% of the global market, reaching USD 21.24 billion in 2025, and is projected to grow at a CAGR of 7.1% during the forecast period. The market is driven by increasing healthcare-associated infection prevention initiatives, rising hospital admissions, expanding adoption of sterilization and disinfection technologies, and stringent regulatory standards for patient safety. Continuous investments in healthcare infrastructure and infection prevention programs continue to support regional market growth.
The US market was valued at USD 18.05 billion in 2025, making it the largest contributor in North America. Increasing demand for advanced sterilization systems, growing healthcare expenditure, expanding infection surveillance programs, and rising adoption of automated disinfection technologies continue to drive market growth.
Canada's market reached USD 3.19 billion in 2025. Growing investments in healthcare infrastructure, increasing awareness of infection prevention, expanding adoption of medical sterilization equipment, and rising implementation of healthcare safety protocols continue to support steady market expansion.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe infection control market accounted for 27.6% of the global market, reaching USD 15.26 billion in 2025, and is projected to grow at a CAGR of 6.8% during the forecast period. Rising demand for advanced sterilization technologies, increasing healthcare quality standards, expanding investments in hospital infection prevention, and stringent regulatory compliance continue to strengthen regional market growth. Continuous technological advancements in infection control solutions further support market expansion.
The UK market was valued at USD 3.05 billion in 2025. Increasing investments in healthcare hygiene, expanding adoption of automated disinfection systems, growing infection prevention initiatives, and rising demand for sterile medical environments continue to support market growth.
Germany market accounted for USD 4.27 billion in 2025. Strong healthcare infrastructure, increasing deployment of sterilization technologies, expanding hospital modernization initiatives, and growing focus on patient safety continue to drive market expansion.
Asia Pacific infection control market accounted for 22.5% of the global market, reaching USD 12.44 billion in 2025, and is projected to grow at a CAGR of 8.9% during the forecast period. Rapid expansion of healthcare infrastructure, increasing awareness of infection prevention, growing investments in hospital modernization, and rising adoption of advanced sterilization equipment continue to accelerate regional market growth. Government initiatives to strengthen public healthcare systems further support market expansion.
China's market accounted for USD 5.22 billion in 2025, representing the largest share within Asia Pacific. Expanding hospital infrastructure, increasing healthcare spending, growing adoption of advanced disinfection technologies, and rising focus on infection prevention continue to drive market expansion.
Japan's market generated USD 2.24 billion in 2025. Increasing demand for high-quality sterilization systems, expanding healthcare modernization, growing elderly population, and rising implementation of infection prevention protocols continue to support market growth.
Middle East and Africa infection control market accounted for 5.1% of the global market, totaling USD 2.82 billion in 2025, and is projected to grow at a CAGR of 7% during the forecast period. Increasing investments in healthcare infrastructure, expanding infection prevention initiatives, growing adoption of sterilization technologies, and rising healthcare awareness continue to support regional market growth.
The UAE market was valued at USD 0.71 billion in 2025. Increasing investments in advanced healthcare facilities, expanding adoption of automated disinfection systems, growing medical tourism, and rising implementation of infection prevention protocols continue to drive market growth.
Africa's market reached USD 2.11 billion in 2025. Expanding healthcare access, increasing investments in hospital infrastructure, growing awareness of infection prevention, and rising adoption of sterilization technologies continue to create long-term growth opportunities across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
Medical Devices Reimbursement Market Size, Share, Growth, 2034
Medical Packaging Market Size, Share, Growth, Analysis, 2034
High Potency API Contract Manufacturing Market Size, Share, Growth, 2034
Healthcare Finance Solutions Market Size, Share, Growth, 2034
Speech Therapy Services Market Size, Share, Growth, Analysis, 2034
Therapeutic Drug Monitoring Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com